CHEST 2023 On Demand Pass-Rapid-Fire: Clinical Challenges of Patients With HAP and VAP

Video Transcription

Video Summary

The video begins with a discussion on clinical challenges with patients who have hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). The speaker presents a case of a 73-year-old man with burns and endotracheal tube in place who develops a fever, thick secretions, and hypoxemia. A molecular test reveals the presence of three organisms: Klebsiella aerogenes, Pseudomonas aeruginosa, and Staphylococcus aureus. The audience is asked which organisms they believe and which ones they would cover. The majority of the audience believes all three organisms are present and votes accordingly. The speaker then discusses the use of molecular testing in diagnosing infections and the challenges associated with interpreting the results. The audience is asked about their experience with molecular testing, and about half of the audience indicates that they have this capability at their facilities. The speaker concludes by discussing the importance of diagnostic testing, including quantitative cultures, and the need for ongoing evaluation and reevaluation of treatment decisions based on clinical improvement and other factors such as procalcitonin levels. The audience is asked about their approach to treatment duration, with the majority indicating that they would discontinue antibiotics after a certain period of time if the patient is showing clinical improvement. The session ends with a discussion on the importance of multidisciplinary collaboration, including pharmacists, in making treatment decisions for HAP and VAP patients.

Meta Tag

Category Chest Infections

Session ID 1130

Speaker Kristina Crothers

Speaker Charles Dela Cruz

Speaker Barbara Jones

Speaker Christian Sandrock

Track Chest Infections

Keywords

hospital-acquired pneumonia

ventilator-associated pneumonia

clinical challenges

molecular test

Klebsiella aerogenes

Pseudomonas aeruginosa

Staphylococcus aureus

diagnosing infections

treatment decisions

multidisciplinary collaboration